Jonathan E. Lim's Insider Trades & SAST Disclosures
Jonathan E. Lim's most recent trade in Erasca Inc was a trade of 2,500,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jonathan E. Lim.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 2,500,000 | 2,500,000 | - | - | Stock option (right to buy) | |
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | 03 Feb 2025 | 2,231,381 | 0 | - | - | Series B Preferred Stock | ||
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | 03 Feb 2025 | 363,703 | 0 | - | - | Series A Preferred Stock | ||
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | 03 Feb 2025 | 270,232 | 307,956 | - | - | Common Stock | ||
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | 03 Feb 2025 | 37,724 | 37,724 | - | - | Common Stock | ||
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 9,086 | 9,086 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 5,704 | 0 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc. | Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 5,704 | 5,704 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 632,759 | 632,759 | - | - | Stock Option (right to buy) | |
| Boundless Bio Inc. | Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 6,610 | 6,610 | - | - | Stock Option (Right to Buy) | |
| Boundless Bio Inc. | Jonathan E. Lim | Director | 02 Apr 2024 | 525,274 | 550,915 | - | - | Common Stock | ||
| Boundless Bio Inc. | Jonathan E. Lim | Director | 02 Apr 2024 | 512,820 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Boundless Bio Inc. | Jonathan E. Lim | Director | 02 Apr 2024 | 7,326 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Boundless Bio Inc. | Jonathan E. Lim | Director | 02 Apr 2024 | 5,128 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Boundless Bio Inc. | Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Erasca Inc | Lim E. Jonathan | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 1,500,000 | 1,500,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Jonathan Lim E. | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 05 Dec 2023 | 721,850 | 12,899,360 | - | 1.7 | 1,217,761 | Common Stock |
| Erasca Inc | Lim E. Jonathan | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 05 Dec 2023 | 278,150 | 12,899,360 | - | 1.7 | 478,418 | Common Stock |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 08 Jun 2023 | 100,000 | 18,396,216 | - | 2.8 | 275,000 | Common Stock |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 1,500,000 | 1,500,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.86 per share. | 10 Jan 2023 | 60,000 | 20,256,222 | - | 3.9 | 231,420 | Common Stock |
| Erasca Inc | Jonathan E. Lim | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 2,000,006 | 18,196,216 | - | 0 | Common Stock | |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.99 per share. | 14 Dec 2022 | 40,000 | 20,196,222 | - | 5.0 | 199,600 | Common Stock |
| Erasca Inc | Jonathan E. Lim | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 791,000 | 791,000 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 6,162,468 | 0 | - | - | Series A Preferred Stock | ||
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 6,081,233 | 0 | - | - | Series A Preferred Stock | ||
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 5,441,027 | 11,899,360 | - | - | Common Stock | ||
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 5,135,390 | 20,156,222 | - | - | Common Stock | ||
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 336,000 | 0 | - | - | Series B-1 Preferred Stock | ||
| Erasca Inc | Jonathan E. Lim | Director, See Remarks, Ten Percent Owner | 20 Jul 2021 | 112,000 | 0 | - | - | Series B-2 Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges